NCT05067387View on ClinicalTrials.gov

Evaluation of Oral THC and CBD in Men and Women

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2028

Conditions
Drug AbuseIntoxication by DrugImpairment
Interventions
DRUG

Placebo

Oral placebo

DRUG

THC

Oral THC (20 mg)

DRUG

CBD

Oral CBD (20 mg)

DRUG

THC + CBD

Oral THC (20 mg) + CBD (20 mg)

Trial Locations (1)

90095

University of California, Los Angeles, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER